Tovorafenib Patent Expiration

Tovorafenib was first introduced by Day One Biopharmaceuticals Inc in its drug Ojemda on Apr 23, 2024.

Tovorafenib Patents

Given below is the list of patents protecting Tovorafenib, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Ojemda US10426782 Pharmaceutical formulations of a pan-RAF kinase inhibitor and processes for their preparation Jun 23, 2035 Day One Biopharms
Ojemda US8293752 Compounds useful as Raf kinase inhibitors Aug 04, 2031 Day One Biopharms

Coming Soon

Patent Strength Analyzer

Will this be useful for you?


Thank you for your response 🥳